Brief: Edgewise Therapeutics Inc As Of Dec 31, 2023, Co Had About $318.4 Million In Cash, Cash Equivalents & Marketable Securities
19/01/2024 11:23
Jan 19 (Reuters) - Edgewise Therapeutics Inc EWTX.O :
* EDGEWISE THERAPEUTICS INC: AS OF DEC 31, 2023, CO HAD
ABOUT
$318.4 MILLION IN CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES
* EDGEWISE THERAPEUTICS- SUSPENDED, TERMINATED PROSPECTUS
RELATED
TO CO’S COMMON STOCK ISSUABLE PURSUANT TO TERMS OF SALES DEAL,
DATED JUNE 16, 2023
Further company coverage: EWTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending